Abstract P2-12-02: Risk of recurrence in real-world (RW) NATALEE- and monarchE-eligible populations of patients with HR+/HER2- early breast cancer (EBC) in an electronic health record (EHR)-derived database
Authors
Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
Giuseppe Curigliano (ORCID: https://orcid.org/0000-0003-1781-2518)
Henry F. Owusu (ORCID: https://orcid.org/0000-0003-2492-0947)
Jason Aboudi Mouabbi (ORCID: https://orcid.org/0000-0001-8689-6845)
Murat Akdere
Komal L. Jhaveri (ORCID: https://orcid.org/0000-0003-0472-1254)
Adam Brufsky (ORCID: https://orcid.org/0000-0001-8080-7960)
Ruth O’Regan
Stephanie L. Graff (ORCID: https://orcid.org/0000-0003-1928-1722)
Abstract P2-12-02: Risk of recurrence in real-world (RW) NATALEE- and monarchE-eligible populations of patients with HR+/HER2- early breast cancer (EBC) in an electronic health record (EHR)-derived database
Erika Hamilton, Giuseppe Curigliano, Henry F. Owusu, Jason Aboudi Mouabbi et al.
Local Database Links
1 links
Journal
Clinical Cancer Research
Topics
Advanced Breast Cancer Therapies
article
Abstract P2-12-02: Risk of recurrence in real-world (RW) NATALEE- and monarchE-eligible populations of patients with HR+/HER2- early breast cancer (EBC) in an electronic health record (EHR)-derived database
Erika Hamilton, Giuseppe Curigliano, Henry F. Owusu, Jason Aboudi Mouabbi, Murat Akdere, Komal L. Jhaveri, Adam Brufsky, Ruth O’Regan, Stephanie L. Graff, Joyce O’Shaughnessy, Paolo Tarantino, Hope S. Rugo, Liz Santarsiero, Julia Kim, Wolfgang Janni, Fen Ye